The Trump administration is tearing down both regulations and the federal government that enforces them. The consequences will be enormous.
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Chimerix (CMRX) announced the FDA has accepted its New Drug Application, or NDA, seeking accelerated approval for dordaviprone as a treatment ...